Role of the investigator in phase 1 trials of anticancer drugs

Lancet Oncol. 2012 Dec;13(12):1177-9. doi: 10.1016/S1470-2045(12)70502-8. Epub 2012 Nov 13.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage*
  • Doxorubicin / administration & dosage*
  • ErbB Receptors / immunology*
  • Female
  • Humans
  • Male
  • Neoplasms / drug therapy*

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin
  • ErbB Receptors